Bipolar Disorder News

HHS has released its “Roadmap for Behavioral Health Integration,” which details policy solutions to help integrate mental health and substance use care into large health care systems.

The FDA has accepted a new drug application for aripiprazole, a 2-month, ready-to-use, long-acting injectable for the treatment of schizophrenia in adults and maintenance monotherapy treatment of bipolar I disorder in adults.

Following the COVID-19 pandemic, the need for mental health care among all age groups is significantly prevalent, while the need for emergency psychiatrists continues to play a role in other aspects of the field.

Introducing electroconvulsive therapy earlier in a treatment course for major depressive disorder or bipolar disorder may lead to improvements in clinical outcomes, according to a study published in the Journal of Clinical Psychiatry.

A majority of adults in the United States agreed on the importance of schools playing a key role in advocating for mental health, according to results of a recent survey from the American Psychiatric Association.

According to a recent poll, overall customer satisfaction with Medicare Advantage plans has increased, yet a majority of plan members say they do not have enough coverage for mental health and substance use disorder services.

The American Psychiatric Association has issued a report detailing a strategy for addressing the crisis of psychiatric bed availability and need.

The American Psychiatric Association Foundation has announced a multiyear grant for $20,000 to U.S.-based nonprofit Languages of Care for its Ukraine Disaster Relief Fund.

Environmental factors play a greater role in the genesis of psychotic experiences than genetic factors among adolescents, according to a study published in JAMA Psychiatry.

LOUISVILLE, Ky. — A speaker at the American Society for Preventive Cardiology Congress on CVD Prevention called on clinicians to have greater consideration for the effects of psychosocial factors on CVD and related outcomes.